Lv1
70 积分 2026-05-05 加入
Peptide–drug conjugate-based novel molecular drug delivery system in cancer
20天前
已完结
DRlinker: Deep Reinforcement Learning for Optimization in Fragment Linking Design
20天前
已完结
Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index
1个月前
已完结
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
1个月前
已完结
The Evolution of Antibody‐Drug Conjugates: Toward Accurate DAR and Multi‐specificity
1个月前
已完结
The novel alkylating prodrug melflufen (J1) inhibits angiogenesis in vitro and in vivo
1个月前
已关闭
A novel alkylating agent Melflufen induces irreversible DNA damage and cytotoxicity in multiple myeloma cells
1个月前
已完结
Pharmacokinetics and Metabolism of Melflufen, an Alkylating Peptide–Drug Conjugate, in Patients with Relapsed Refractory Multiple Myeloma
1个月前
已完结
Peptide–Drug Conjugates with Different Linkers for Cancer Therapy
1个月前
已完结
Recent Advances in Targeted Cancer Therapy: Are PDCs the Next Generation of ADCs?
1个月前
已完结
皖公网安备34019202002308
